Metabolism - Clinical and Experimental
Volume 59, Issue 12 , Pages 1775-1783, December 2010

Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population

  • Paul M. Coen

      Affiliations

    • Wastl Human Performance Laboratory, Purdue University, West Lafayette, IN
    • Corresponding Author InformationCorresponding author.
  • ,
  • Michael G. Flynn

      Affiliations

    • Wastl Human Performance Laboratory, Purdue University, West Lafayette, IN
  • ,
  • Melissa M. Markofski

      Affiliations

    • Wastl Human Performance Laboratory, Purdue University, West Lafayette, IN
  • ,
  • Brandt D. Pence

      Affiliations

    • Wastl Human Performance Laboratory, Purdue University, West Lafayette, IN
  • ,
  • Robert E. Hannemann

      Affiliations

    • Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN

Received 7 February 2010; accepted 3 May 2010. published online 28 June 2010.

Abstract 

Statin treatment and exercise training can reduce markers of inflammation when administered separately. The purpose of this study was to determine the effect of rosuvastatin treatment and the addition of exercise training on circulating markers of inflammation including C-reactive protein (CRP), monocyte toll-like receptor 4 (TLR4) expression, and CD14+CD16+ monocyte population size. Thirty-three hypercholesterolemic and physically inactive subjects were randomly assigned to rosuvastatin (R) or rosuvastatin/exercise (RE) groups. A third group of physically active hypercholesterolemic subjects served as a control (AC). The R and RE groups received rosuvastatin treatment (10 mg/d) for 20 weeks. From week 10 to week 20, the RE group also participated in an exercise training program (3d/wk). Measurements were made at baseline (Pre), week 10 (Mid), and week 20 (Post), and included TLR4 expression on CD14+ monocytes and CD14+CD16+ monocyte population size as determined by 3-color flow cytometry. Serum CRP was quantified by enzyme-linked immunosorbent assay. TLR4 expression on CD14+ monocytes was higher in the R group at week 20. When treatment groups (R and RE) were combined, serum CRP was lower across time. Furthermore, serum CRP and inflammatory monocyte population size were lower in the RE group compared with the R group at the Post time point. When all groups (R, RE, and AC) were combined, TLR4 expression was greater on inflammatory monocytes (CD14+CD16+) compared with classic monocytes (CD14+CD16−) at all time points. In conclusion, rosuvastatin may influence monocyte inflammatory response by increasing TLR4 expression on circulating monocytes. The addition of exercise training to rosuvastatin treatment further lowered CRP and reduced the size of the inflammatory monocyte population, suggesting an additive anti-inflammatory effect of exercise.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Institutional approval: This study was approved by the Biomedical Institutional Review Board at Purdue University (protocol 0505002668).

PII: S0026-0495(10)00155-1

doi:10.1016/j.metabol.2010.05.002

Metabolism - Clinical and Experimental
Volume 59, Issue 12 , Pages 1775-1783, December 2010